Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Lipari Mining and SpurChain Partner to Tokenize Natural Diamond Production (click to learn more)

CNS Pharmaceuticals Inc CNSP

Healthcare Biotechnology

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. The Company's drug candidate, TPI 287, is an abeotaxane which stabilizes microtubules and inhibits cell division, causing apoptosis and cell death. TPI 287 has shown the potential to cross the blood-brain barrier and treat central nervous system (CNS) tumors.

NDAQ:CNSP - Post by User

CNS Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

(317)
•••

Post by Iseneschalon Apr 14, 2023 1:18pm

154 Views

Post# 35395569

CNSP..... Checkout 04/06/23 trading

Enter Symbol
or Name

USA
CA

Quote
Chart

News
Closes

Depth

You are logged in: sl1scorpio

Close Prices Last 3 Months

Price/volumes not adjusted for restructures

Date	Ex	Sym	Open	High	Low	Close	Chg	Vol	#Tr	Bid	Ask
2023-04-13	Q	CNSP	0.72	0.72	0.6701	0.685	0.004	150,227	244
2023-04-12	Q	CNSP	0.6999	0.72	0.6601	0.681	-0.0223	293,051	320
2023-04-11	Q	CNSP	0.7399	0.7699	0.6801	0.7002	-0.0459	436,588	836
2023-04-10	Q	CNSP	0.7142	0.7725	0.6105	0.7492	-0.0009	934,651	1,765
2023-04-06	Q	CNSP	1.33	1.41	0.7011	0.7501	-0.1474	12,639,820	13,287
2023-04-05	Q	CNSP	0.9187	0.9187	0.85	0.866	-0.0225	25,056	71